IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $110,899 | +88619.2% | 11,516 | -1.8% | 0.01% | 0.0% |
| Q2 2023 | $125 | -99.9% | 11,726 | -12.0% | 0.01% | -22.2% |
| Q3 2022 | $138,000 | -13.2% | 13,326 | -3.5% | 0.01% | -10.0% |
| Q2 2022 | $159,000 | -11.2% | 13,808 | -2.8% | 0.01% | 0.0% |
| Q1 2022 | $179,000 | +2.3% | 14,199 | -5.6% | 0.01% | +11.1% |
| Q4 2021 | $175,000 | -21.5% | 15,035 | -13.1% | 0.01% | -25.0% |
| Q2 2021 | $223,000 | +54.9% | 17,294 | +34.2% | 0.01% | +33.3% |
| Q1 2021 | $144,000 | – | 12,883 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |